The NHS has a word of warning on its website for anyone who is taking metformin, though it is especially aimed at people who ...

The NHS has issued a cautionary note on its website for those taking metformin, particularly those who have been on the ...

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

Vitamin B12 plays a crucial role in maintaining a healthy nervous system; its deficiency can lead to nerve damage, resulting ...

The company has announced positive data from the ACHIEVE-2 and ACHIEVE-5 trials, with both meeting all their primary and key ...

Polycystic ovary syndrome affects millions of women worldwide, causing reproductive and metabolic issues, but often goes ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by ...

Type 2 diabetes can lead to a number of health complications, but making certain dietary choices can help manage blood sugar ...

The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...

Eli Lilly's oral GLP-1 pill orforglipron delivers strong A1C reductions in two late-stage diabetes studies, reinforcing its ...